You are here

  • Home
  • Archive
  • Volume 79, Issue 8
  • Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero

Article Text

Article menu

Download PDFPDF

Correspondence
Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero
Free
  1. Hasan Satış1,
  2. Reyhan Bilici Salman1,
  3. Aslihan Avanoğlu Güler1,
  4. Hazan Karadeniz1,
  5. Şeyma Yıldız2,
  6. Neslihan Kayahan3
  1. 1 Rheumatology Deparment, Gazi University, Ankara, Turkey
  2. 2 Internal Medicine Deparment, Gazi University, Ankara, Turkey
  3. 3 Department of Internal Medicine, Gülhane Egitim ve Arastirma Hastanesi, Ankara, Turkey
  1. Correspondence to Dr Hasan Satış, Gazi University, Ankara 06500, Turkey; hasansats{at}gmail.com

https://doi.org/10.1136/annrheumdis-2019-215542

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the article ‘Comorbidity and Long-Term Outcome in Patients with Congenital Heart Block and Their Siblings Exposed to Ro/SSA Autoantibodies In Utero’ by Mofors et al.1 A large and long-term follow-up population consisting of patients with congenital heart block (CHB) as a result of in utero Ro/SSA autoantibody exposure were studied. It contributes valuable information to our knowledge; however, …

    View Full Text

    Linked Articles